Asc-1 Transporter (SLC7A10): Homology Models And Molecular Dynamics Insights Into The First Steps Of The Transport Mechanism

被引:0
作者
Afaf Mikou
Alexandre Cabayé
Anne Goupil
Hugues-Olivier Bertrand
Jean-Pierre Mothet
Francine C. Acher
机构
[1] Laboratoire de Chimie et Biochimie Pharmacologiques et Toxicologiques,
[2] UMR 8601 CNRS,undefined
[3] Université de Paris,undefined
[4] BIOVIA,undefined
[5] Dassault Systèmes,undefined
[6] 10 rue Marcel Dassault,undefined
[7] CS 40501,undefined
[8] LuMIn FRE2036,undefined
[9] Université Paris-Saclay,undefined
[10] CNRS,undefined
[11] ENS Paris-Saclay,undefined
[12] CentraleSupélec,undefined
来源
Scientific Reports | / 10卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The alanine-serine-cysteine transporter Asc-1 regulates the synaptic availability of d-serine and glycine (the two co-agonists of the NMDA receptor) and is regarded as an important drug target. To shuttle the substrate from the extracellular space to the cytoplasm, this transporter undergoes multiple distinct conformational states. In this work, homology modeling, substrate docking and molecular dynamics simulations were carried out to learn more about the transition between the “outward-open” and “outward-open occluded” states. We identified a transition state involving the highly-conserved unwound TM6 region in which the Phe243 flips close to the d-serine substrate without major movements of TM6. This feature and those of other key residues are proposed to control the binding site and substrate translocation. Competitive inhibitors ACPP, LuAE00527 and SMLC were docked and their binding modes at the substrate binding site corroborated the key role played by Phe243 of TM6. For ACPP and LuAE00527, strong hydrophobic interactions with this residue hinder its mobility and prevent the uptake and the efflux of substrates. As for SMLC, the weaker interactions maintain the flexibility of Phe243 and the efflux process. Overall, we propose a molecular basis for the inhibition of substrate translocation of the Asc-1 transporter that should be valuable for rational drug design.
引用
收藏
相关论文
共 94 条
  • [81] Shi Y(undefined)undefined undefined undefined undefined-undefined
  • [82] Closs EI(undefined)undefined undefined undefined undefined-undefined
  • [83] Boissel J-P(undefined)undefined undefined undefined undefined-undefined
  • [84] Habermeier A(undefined)undefined undefined undefined undefined-undefined
  • [85] Rotmann A(undefined)undefined undefined undefined undefined-undefined
  • [86] Kutchukian PS(undefined)undefined undefined undefined undefined-undefined
  • [87] Bartoccioni P(undefined)undefined undefined undefined undefined-undefined
  • [88] Fort J(undefined)undefined undefined undefined undefined-undefined
  • [89] Zorzano A(undefined)undefined undefined undefined undefined-undefined
  • [90] Errasti-Murugarren E(undefined)undefined undefined undefined undefined-undefined